Huntington National Bank raised its position in shares of Humana Inc. (NYSE:HUM) by 3.1% during the second quarter, Holdings Channel reports. The fund owned 16,134 shares of the insurance provider’s stock after buying an additional 491 shares during the period. Huntington National Bank’s holdings in Humana were worth $2,902,000 as of its most recent filing with the SEC.
Other hedge funds have also added to or reduced their stakes in the company. Daiwa SB Investments Ltd. boosted its stake in Humana by 7.5% in the second quarter. Daiwa SB Investments Ltd. now owns 720 shares of the insurance provider’s stock worth $132,000 after buying an additional 50 shares during the last quarter. Bessemer Group Inc. boosted its stake in Humana by 392.6% in the first quarter. Bessemer Group Inc. now owns 1,000 shares of the insurance provider’s stock worth $183,000 after buying an additional 797 shares during the last quarter. Spark Investment Management LLC acquired a new stake in Humana during the first quarter worth about $274,000. Trust Co boosted its stake in Humana by 12.4% in the first quarter. Trust Co now owns 1,720 shares of the insurance provider’s stock worth $315,000 after buying an additional 190 shares during the last quarter. Finally, Checchi Capital Advisers LLC boosted its stake in Humana by 3.1% in the second quarter. Checchi Capital Advisers LLC now owns 2,196 shares of the insurance provider’s stock worth $395,000 after buying an additional 67 shares during the last quarter. 93.24% of the stock is owned by institutional investors.
Shares of Humana Inc. (NYSE:HUM) traded up 0.79% during trading on Friday, hitting $170.82. The stock had a trading volume of 1,447,892 shares. The company has a market cap of $25.46 billion, a PE ratio of 26.24 and a beta of 0.90. The firm’s 50 day moving average is $175.94 and its 200 day moving average is $175.74. Humana Inc. has a 1-year low of $150.00 and a 1-year high of $191.65.
Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, August 3rd. The insurance provider reported $2.30 EPS for the quarter, beating the consensus estimate of $2.23 by $0.07. Humana had a return on equity of 11.11% and a net margin of 1.76%. The business had revenue of $14 billion for the quarter, compared to the consensus estimate of $13.59 billion. During the same quarter in the prior year, the business earned $1.67 earnings per share. Humana’s revenue for the quarter was up 2.0% on a year-over-year basis. Equities research analysts anticipate that Humana Inc. will post $9.24 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Thursday, October 13th will be paid a $0.29 dividend. The ex-dividend date is Tuesday, October 11th. This represents a $1.16 annualized dividend and a yield of 0.68%. Humana’s payout ratio is 18.18%.
A number of analysts have recently issued reports on HUM shares. Zacks Investment Research raised Humana from a “hold” rating to a “buy” rating and set a $197.00 price objective for the company in a research report on Monday, July 25th. Jefferies Group reissued a “buy” rating and set a $220.00 price target (up from $210.00) on shares of Humana in a report on Monday, July 25th. RBC Capital Markets reissued a “buy” rating and set a $224.00 price target (up from $220.00) on shares of Humana in a report on Friday, July 22nd. Cantor Fitzgerald reissued a “buy” rating on shares of Humana in a report on Saturday, July 9th. Finally, Evercore ISI began coverage on Humana in a report on Thursday, September 22nd. They set a “buy” rating and a $200.00 price target for the company. Seven research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Humana presently has an average rating of “Buy” and an average price target of $200.50.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.